Handbook of Bioentrepreneurship [recurso electrónico] / edited by Thomas Brenner, Holger Patzelt.

to the Handbook of Bioentrepreneurship -- Biotechnology Dynamics at the Global Scale -- Geographic Clustering in Biotechnology: Social Networks and Firm Foundings -- Innovation Networks in Biotechnology -- Strategy and Strategic Thinking in Biotechnology Entrepreneurship -- Research on Strategic Alliances in Biotechnology: An Assessment and Review -- Mergers and Acquisitions in the Biotechnology Industry -- Synergy, Strategy, and Serendipity: Kirin Brewery's Entry into Biopharmaceuticals -- A Survey Review of University Biotechnology and Entrepreneurship Commercialization -- University-Based Biotechnology Spin-Offs -- Patenting Biotechnology -- Legal Frameworks and Public Support in the Biotechnology Industry.

Providing an important and timely overview of research in the field of entrepreneurship in biotechnology, The Handbook of Bioentrepreneurship examines one of the most promising industries of the 21st century. While genetically engineered foods and biopharmaceuticals have made biotechnology part of our everyday lives, launching a bioventure is among the most complex and risky entrepreneurial undertakings, given long development cycles, high levels of technological and market uncertainty, and extraordinary capital requirements. Featuring unparalleled, in-depth analysis from experts around the world, the Handbook sheds light on emerging business models and strategies, geographical and regional networks, cooperation between firms and universities, legal frameworks, and policy issues that influence the context in which biotech ventures are established and the conditions under which they may flourish. Reviewing and showcasing state-of-the-art data, examples, theoretical insights, and practical applications, the Handbook will serve as an essential resource for researchers and students in entrepreneurship, corporate strategy, technology management, and economic policy, as well as business leaders, investors, scientists, and policymakers with a stake in the dynamic, high-growth industry of biotechnology.